Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression

Author:

Long Georgina V.1,Weber Jeffrey S.2,Larkin James3,Atkinson Victoria4,Grob Jean-Jacques5,Schadendorf Dirk6,Dummer Reinhard7,Robert Caroline8,Márquez-Rodas Ivan9,McNeil Catriona10,Schmidt Henrik11,Briscoe Karen12,Baurain Jean-François13,Hodi F. Stephen14,Wolchok Jedd D.15

Affiliation:

1. Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia3Mater Hospital, North Sydney, New South Wales, Australia

2. Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida5now with Department of Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York

3. Department of Oncology, Royal Marsden Hospital, London, United Kingdom

4. Gallipoli Medical Research Foundation and Princess Alexandra Hospital, and University of Queensland, Queensland, Australia

5. Department of Dermatology and Skin Cancer, Hospital Timone APHM, Aix-Marseille University, Marseille, France

6. Department of Skin, University Hospital Essen, Essen, Germany10Department of Urology, University Hospital Essen, Essen, Germany

7. Department of Dermatology, UniversitaetsSpital, Zurich, Switzerland

8. Department of Medicine Institute Gustave Roussy, Gustave Roussy and Paris-Sud University, Villejuif Paris-Sud, France

9. Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain

10. Chris O’Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales, Australia15Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

11. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

12. Department of Medical Oncology, Coffs Harbour Health Campus, New South Wales, Australia

13. Melanoma Clinic at King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium

14. Melanoma Center and Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

15. Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3